A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease

• Status: Completed
• Trial end date: 2015-03-16
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the safety and efficacy o fRefresh Optive® Gel Drops in patients with dry eye disease.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Carboxymethylcellulose Sodium; Ophthalmic Solutions; Tetrahydrozoline

Criteria

Inclusion Criteria:

• Current use of an artificial tear product

• Visual acuity of at least 20/32 (while wearing glasses, if necessary).

Exclusion Criteria:

• Use of contact lenses in the last 3 months, or anticipated use of contact lenses during the study

• Cataract surgery, laser-assisted in situ keratomileusis [LASIK], or photorefractive keratectomy, within the last 6 months

• Current eye infection or inflammation